APA (7th ed.) Citation

SJ, R., L, O., R, T., M, S., F, N., AM, P., . . . M, S. (2021). Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi. JAMA dermatology, 157(7), 836. https://doi.org/10.1001/jamadermatol.2021.0025

Chicago Style (17th ed.) Citation

SJ, Robertson, et al. "Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi." JAMA Dermatology 157, no. 7 (2021): 836. https://doi.org/10.1001/jamadermatol.2021.0025.

MLA (9th ed.) Citation

SJ, Robertson, et al. "Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi." JAMA Dermatology, vol. 157, no. 7, 2021, p. 836, https://doi.org/10.1001/jamadermatol.2021.0025.